{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T20:53:30Z","timestamp":1747169610692,"version":"3.40.5"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Nantong Applied Research Project","award":["MS12015006","MS12017008-2"],"award-info":[{"award-number":["MS12015006","MS12017008-2"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.prp.2019.01.001","type":"journal-article","created":{"date-parts":[[2019,1,19]],"date-time":"2019-01-19T12:26:50Z","timestamp":1547900810000},"page":"748-754","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Association of hCG and LHCGR expression patterns with clinicopathological parameters in ovarian cancer"],"prefix":"10.1016","volume":"215","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9609-1626","authenticated-orcid":false,"given":"Yuanyuan","family":"Zhong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianfei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangyu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weidong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sainan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuquan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2019.01.001_bib0005","doi-asserted-by":"crossref","first-page":"41330","DOI":"10.1038\/srep41330","article-title":"Upregulation of MiR-205 transcriptionally suppresses SMAD4 and PTEN and contributes to human ovarian cancer progression","volume":"7","author":"Li","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2019.01.001_bib0010","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1038\/nm.2512","article-title":"miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response","volume":"17","author":"Mateescu","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.prp.2019.01.001_bib0015","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/path.4443","article-title":"MiR-506 inhibits multiple targets in the epithelial-to-mesenchymal transition network and is associated with good prognosis in epithelial ovarian cancer","volume":"235","author":"Sun","year":"2015","journal-title":"J. Pathol."},{"key":"10.1016\/j.prp.2019.01.001_bib0020","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000486770","article-title":"B subunit of human chorionic gonadotropin promotes tumor invasion and predicts poor prognosis of early-stage colorectal cancer","volume":"45","author":"Li","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.prp.2019.01.001_bib0025","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.3390\/ijms18071587","article-title":"Human chorionic gonadotropin and breast cancer","volume":"18","author":"Sch\u00fcler-Toprak","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2019.01.001_bib0030","first-page":"1479","article-title":"Expression and secretion of the beta subunit of human chorionic gonadotropin by bladdercarcinoma in vivo and in vitro","volume":"55","author":"Nishimura","year":"1995","journal-title":"Cancer Res."},{"issue":"104","key":"10.1016\/j.prp.2019.01.001_bib0035","article-title":"Tumor budding and human chorionic gonadotropin-beta expression correlate with unfavorable patient outcome in colorectal carcinoma","volume":"35","author":"Konishi","year":"2018","journal-title":"Med. Oncol."},{"key":"10.1016\/j.prp.2019.01.001_bib0040","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/j.1525-1438.2007.01151.x","article-title":"Coexpression of human chorionic gonadotropin beta subunit and its receptor in nontrophoblastic gynecological cancer","volume":"18","author":"Jankowska","year":"2008","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.prp.2019.01.001_bib0045","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.3892\/or.2017.5818","article-title":"Human chorionic gonadotropin beta regulates epithelial-mesenchymal transition and metastasis in human ovarian cancer","volume":"38","author":"Liu","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.prp.2019.01.001_bib0050","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3892\/or.2015.4386","article-title":"Human chorionic gonadotropin \u03b2 subunit affects the expression of apoptosis-regulating factors in ovarian cancer","volume":"35","author":"Szczerba","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.prp.2019.01.001_bib0055","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1146\/annurev-cellbio-092910-154036","article-title":"The ins and outs of the epithelial to mesenchymal transition in health and disease","volume":"27","author":"Nieto","year":"2011","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.prp.2019.01.001_bib0060","first-page":"1483","article-title":"Increased expression of luteinizing hormone\/human chorionic gonadotropin receptor gene in human endometrial carcinomas","volume":"79","author":"Lin","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.prp.2019.01.001_bib0065","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1618056","article-title":"Luteinizing Hormone\/Human chorionic gonadotropin receptor immunohistochemical score associated with poor prognosis in endometrial cancer patients","volume":"2018","author":"Sorbi","year":"2018","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.prp.2019.01.001_bib0070","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ygyno.2008.08.018","article-title":"hLH\/hCG-receptor expression correlates with in vitro invasiveness in human primary endometrial cancer","volume":"111","author":"Noci","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.prp.2019.01.001_bib0075","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1210\/edrv.23.2.0462","article-title":"The lutropin\/choriogonadotropin receptor, a 2002 perspective","volume":"23","author":"Ascoli","year":"2002","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.prp.2019.01.001_bib0080","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1210\/er.2006-0036","article-title":"Gonadotropins and ovarian cancer","volume":"28","author":"Choi","year":"2007","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.prp.2019.01.001_bib0085","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/humupd\/dml002","article-title":"Endocrine signaling in ovarian surface epithelium and cancer","volume":"13","author":"Leung","year":"2007","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.prp.2019.01.001_bib0090","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.mce.2010.04.028","article-title":"Are gonadotrophins tumorigenic--a critical review of clinical and experimental data","volume":"329","author":"Huhtaniemi","year":"2010","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.prp.2019.01.001_bib0095","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1097\/IGC.0b013e31822c7529","article-title":"Role of hCG in vasculogenic mimicry in OVCAR-3 ovarian cancer cell line","volume":"21","author":"Su","year":"2011","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.prp.2019.01.001_bib0100","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/14737159.2017.1326820","article-title":"The role of biomarkers in the management of epithelial ovarian cancer","volume":"17","author":"Yang","year":"2017","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/j.prp.2019.01.001_bib0105","doi-asserted-by":"crossref","first-page":"12104","DOI":"10.1038\/srep12104","article-title":"Overexpression of MAGE-A9 is predictive of poor prognosis in epithelial ovarian cancer","volume":"5","author":"Xu","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2019.01.001_bib0110","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s12032-017-1026-y","article-title":"Ovarian cancer recurrence and early detection: may HE4 play a key role in this open challenge? A systematic review of literature","volume":"34","author":"Capriglione","year":"2017","journal-title":"Med. Oncol."},{"key":"10.1016\/j.prp.2019.01.001_bib0115","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s00256-017-2647-0","article-title":"Elevated beta-hCG associated with aggressive Osteoblastoma","volume":"46","author":"Morris","year":"2017","journal-title":"Skeletal Radiol."},{"key":"10.1016\/j.prp.2019.01.001_bib0120","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1006\/mcpr.2002.0421","article-title":"Increased expression of human luteinizing hormone\/human chorionic gonadotropin receptor mRNA in human endometrial cancer","volume":"16","author":"Ji","year":"2002","journal-title":"Mol. Cell. Probes"},{"key":"10.1016\/j.prp.2019.01.001_bib0125","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.tem.2018.02.012","article-title":"Endocrine, paracrine, and autocrine signaling pathways that regulate ovulation","volume":"29","author":"Richards","year":"2018","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.prp.2019.01.001_bib0130","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.rbmo.2016.03.003","article-title":"Luteinizing hormone\/chorionic gonadotrophin receptor overexpressed in granulosa cells from polycystic ovary syndrome ovaries is functionally active","volume":"32","author":"Kanamarlapudi","year":"2016","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.prp.2019.01.001_bib0135","first-page":"1264","article-title":"Isolation of TSH and LH\/CG receptor cDNAs from human thyroid: regulation by tissue specific splicing","volume":"4","author":"Frazier","year":"1990","journal-title":"MolecularEndocrinology"},{"key":"10.1016\/j.prp.2019.01.001_bib0140","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1210\/jc.2003-031882","article-title":"Presence of luteinizing hormone\/human chorionic gonadotropin receptors in male breast tissues","volume":"89","author":"Carlson","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.prp.2019.01.001_bib0145","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/IGC.0b013e3181bbe933","article-title":"Expression of hCG and GnRHs and their receptors in endometrial carcinoma and hyperplasia","volume":"20","author":"Jankowska","year":"2010","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.prp.2019.01.001_bib0150","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.mce.2006.11.014","article-title":"LH\/hCG action and development of ovarian cancer--a short review on biological and clinical\/epidemiological aspects","volume":"269","author":"Mandai","year":"2007","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.prp.2019.01.001_bib0155","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13048-017-0325-4","article-title":"Prohibitin: targeting peptide coupled to ovarian cancer, luteinization and TGF-beta pathways","volume":"10","author":"El-Etreby","year":"2017","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.prp.2019.01.001_bib0160","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.mce.2008.12.016","article-title":"LH receptor gene expression is essentially absent in breast tumor tissue: implications for treatment","volume":"302","author":"Kuijper","year":"2009","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.prp.2019.01.001_bib0165","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/1471-2407-11-280","article-title":"Regulation of gene expression in ovarian cancer cells by luteinizing hormone receptor expression and activation","volume":"11","author":"Cui","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prp.2019.01.001_bib0170","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1210\/endo-128-1-388","article-title":"Evidence that human chorionic gonadotropin\/luteinizing hormone receptor down-regulation involves decreased levels of receptor messenger ribonucleic acid","volume":"128","author":"Hoffman","year":"1991","journal-title":"Endocrinology"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033818313153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033818313153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T19:22:00Z","timestamp":1553282520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033818313153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0344033818313153"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2019.01.001","relation":{},"ISSN":["0344-0338"],"issn-type":[{"type":"print","value":"0344-0338"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of hCG and LHCGR expression patterns with clinicopathological parameters in ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2019.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}